DCTs’ Broader and Multifaceted Implications
Moving forward in a DCT world.
The decentralized clinical trial (DCT) movement has become the “it” word in the post-pandemic clinical trials world. In cases of enormous hype, where a term is used over and over, as well as used as an umbrella term to mean multiple things, it becomes less descriptive and, therefore, more confusing.
Now when decentralized clinical trial articles are submitted to our editors, they must begin with what the core article topic is…not decentralized trials, not a historical restating of the facts of how DCTs came to be…not a reairing of all the possible benefits DCTs could bring to the industry. No. What we need now are specifics. Directions. Best practices. Or even things that were tried and didn’t work well.
But what I will concede is that DCTs have brought a whole new cast of characters into the clinical trials mix. And old characters proving that adaptability makes competitive sense.
Internal server error